Skip to main content
AmigoFish

Renewed Potential: Reviving an ALS Drug...Dr. Ari Azhir, Founder & CEO, Neuvivo

From BioTech Nation ... with Dr. Moira Gunn · · 17 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a crucial mistake in the trial data. Now with new insights and groundbreaking survival results, Neuvivo is giving hope to ALS patients and exploring its potential for other neurodegenerative diseases like Huntington’s and Alzheimer’s.

Back to BioTech Nation ... with Dr. Moira Gunn · Report a problem